Want to join the conversation?
In 1Q16, $SXT's Flavors & Fragrances' revenue, in local currency, was off approx. 1% and operating income was off by approx. 7.5% versus 1Q15. The company is maintaining its expectations for high single digit profit growth in local currency for the year. In Asia-Pacific, revenue grew 9% and profit grew 13% in local currency.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.